Fundz

Agenus Inc. raises $85 million in a private placement led by Commodore Capital to advance its ROBBIN trial for colon cancer, with potential total proceeds of $340 million.

PUBLIC · AGENJul 13, 2026

Amount Raised

$85 Million

Round Type

Post-IPO Equity

LexingtonBiotechnology

Investors

RA Capital ManagementInvusTcgxCommodore Capital

Description

Agenus Inc. has announced a private placement to raise approximately $85 million in upfront gross proceeds, with a potential total of up to $340 million. The financing will support the company's ROBBIN trial for neoadjuvant BOT+BAL in MSS colon cancer. The round was led by Commodore Capital and included notable participants

Quick answer

Agenus raised $85 Million in a Post-IPO Equity round, dated July 13, 2026. Investors: RA Capital Management, Invus, Tcgx and Commodore Capital. Agenus is based in Lexington, Massachusetts, United States.

How much did Agenus raise?
Agenus raised $85 Million in a Post-IPO Equity round on July 13, 2026.
Who invested in Agenus?
RA Capital Management, Invus, Tcgx and Commodore Capital are named as investors in this round.
What does Agenus do?
Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents.
Where is Agenus based and how big is it?
Agenus is based in Lexington, Massachusetts, United States. Fundz records about 81 employees.
Who are the decision-makers at Agenus?
Fundz holds 2 contacts at Agenus. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Agenus that raised within 45 days of this round, from Fundz verified event records.

  • BioLineRx Ltd raised $3.8M on August 27, 2026.
  • StrataBio raised $25K (Pre-Seed) on August 27, 2026.
  • Adaptyv Bio raised $40M (Series A) on August 27, 2026.
  • Redx raised $36M (Series A) on August 27, 2026.
  • Tempo Therapeutics raised $15M on August 27, 2026.
  • Gestala Technology raised $84M (Angel) on August 26, 2026.

Who to call at Agenus, and when

A new round usually means Agenus is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Agenus raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Agenus, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Agenus. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Agenus

Location

3 Forbes Road

Lexington, Massachusetts, United States

About

Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Agenus raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts34 people are listed at Agenus. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Agenus's next move

See what Strategic adds

Agenus raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.